4:32 PM
 | 
Apr 03, 2013
 |  BC Extra  |  Company News

U.K., Germany approve GSK's quadrivalent flu vaccine

GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) said Germany and the U.K. approved its quadrivalent seasonal flu vaccine under the EU's decentralized procedure to prevent influenza subtypes A and B infection in people...

Read the full 134 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >